WHO Issues Concern Over Acute Lack of Obesity Injections

Under 10% of individuals that would benefit from GLP-1 drugs including Wegovy have access to them, caution the global health agency as it publishes its inaugural recommendations on the therapies.

With more than one billion people worldwide currently classified as obese, it is urging increased and just availability to GLP-1 medication.

According to forecasts, in excess of 2,000,000,000 could be living with obesity by 2030 if no action is taken.

"Our latest guidance acknowledges that excess weight is a lifelong illness that can be managed with comprehensive and continuous support," remarked the agency's head Tedros Adhanom Ghebreyesus.

Substantial prices, insufficient output, and distribution challenges are significant obstacles to widespread access to the injections that can aid individuals in losing considerable weight, says the organization.

Weight-Loss Drug Supply Crisis

Despite the current most optimistic scenario, the manufacturing of GLP-1 therapies would only suffice for approximately 100 million people – less than 10% of the global need, as stated by the health organization.

The advice calls on governments and firms to increase access, through strategies including licensing agreements.

A patent on a key compound – the core component of Novo Nordisk's Wegovy – is scheduled to end in several nations in 2026.

How Weight-Loss Drugs Work

The injections replicate a biological compound to delay gastric emptying, curb appetite and enhance satiety so users eat less.

Patients usually see weight reduction in the initial weeks of beginning the regular doses.

Studies indicates people may put most of the weight back on a year later of stopping the medication, because their normal appetite return.

To be above a healthy weight increases your likelihood for contracting medical conditions, like type 2 diabetes, heart disease, stroke, and specific malignancies.

Obesity impacts individuals in all nations and was associated with over three and a half million deaths worldwide in 2024, as per the WHO.